Bank of New York Mellon Corp Cuts Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Bank of New York Mellon Corp cut its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 4.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 170,481 shares of the medical instruments supplier’s stock after selling 8,266 shares during the quarter. Bank of New York Mellon Corp owned about 0.75% of LeMaitre Vascular worth $14,303,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in shares of LeMaitre Vascular during the fourth quarter worth $14,900,000. Rockefeller Capital Management L.P. bought a new stake in shares of LeMaitre Vascular during the fourth quarter worth $7,787,000. Segall Bryant & Hamill LLC bought a new stake in shares of LeMaitre Vascular during the fourth quarter worth $5,446,000. Invesco Ltd. lifted its position in shares of LeMaitre Vascular by 50.5% during the fourth quarter. Invesco Ltd. now owns 174,998 shares of the medical instruments supplier’s stock worth $16,124,000 after purchasing an additional 58,720 shares during the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of LeMaitre Vascular by 7,486.5% during the first quarter. GAMMA Investing LLC now owns 53,864 shares of the medical instruments supplier’s stock worth $4,519,000 after purchasing an additional 53,154 shares during the last quarter. 84.64% of the stock is currently owned by institutional investors.

LeMaitre Vascular Stock Performance

LMAT stock opened at $79.77 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 16.49 and a quick ratio of 13.83. The business has a 50-day moving average price of $82.82 and a 200 day moving average price of $87.74. The company has a market capitalization of $1.80 billion, a P/E ratio of 40.29, a PEG ratio of 2.10 and a beta of 0.82. LeMaitre Vascular, Inc. has a 1-year low of $71.42 and a 1-year high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT) last posted its earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.02). LeMaitre Vascular had a net margin of 19.96% and a return on equity of 13.53%. The company had revenue of $59.87 million during the quarter, compared to analysts’ expectations of $57.61 million. During the same quarter last year, the firm earned $0.44 EPS. LeMaitre Vascular’s revenue for the quarter was up 12.0% on a year-over-year basis. As a group, equities research analysts forecast that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend was Thursday, May 15th. LeMaitre Vascular’s dividend payout ratio (DPR) is 40.40%.

Insider Activity at LeMaitre Vascular

In other LeMaitre Vascular news, CEO George W. Lemaitre sold 4,399 shares of the business’s stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $85.10, for a total value of $374,354.90. Following the completion of the transaction, the chief executive officer directly owned 1,827,003 shares of the company’s stock, valued at approximately $155,477,955.30. The trade was a 0.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders sold a total of 100,000 shares of company stock worth $8,556,857 over the last three months. Insiders own 9.50% of the company’s stock.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.